Pulmonary and systemic inflammatory responses in rabbits with gram- negative pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 6, 1997, Pages 2030-2040

  Fox Dewhurst, Rebecca ^b   Alberts, Michael K ^b   Kajikawa, Osamu ^b   Caldwell, Ellen ^b   Johnson II, Martin C ^b   Skerrett, Shawn J ^b   Goodman, Richard B ^b   Ruzinski, John T ^b   Wong, Venus A ^b   Chi, Emil Y ^b   Martin, Thomas R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; GRAM NEGATIVE BACTERIUM; HISTOPATHOLOGY; INFLAMMATION; LUNG CLEARANCE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RABBIT; SEPTIC SHOCK;

EID: 8244235142     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.6.9196112     Document Type: Article

References (33)

1. Hudson, L. D., J. A. Milberg, D. Anardi, and R. J. Maunder. 1995. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:293-301.
2. Parillo, J. E., M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Cunnion, and F. P. Ognibene. 1990. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227-242.
3. Martin, M. A., and H. J. Silverman. 1992. Gram-negative sepsis and the adult respiratory distress syndrome. J. Infect. Dis. 14:1213-1228.
4. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, and R. M. Schein. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 101:1644-1655.
5. The problem of sepsis. An expert report of the European Society of Intensive Care Medicine. 1994. Intensive Care Med. 20:300-304.
6. Nelson, S., G. J. Bagby, B. G. Bainton, L. A. Wilson, J. J. Thompson, and W. R. Summer. 1989. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J. Infect. Dis. 159:189-194.
7. Martin, T. R., J. T. Ruzinski, C. B. Wilson, and S. J. Skerrett. 1995. Effects of endotoxin in the lungs of neonatal rats: age-dependent impairment of the inflammatory response. J. Infect. Dis. 171:334-344.
8. Kajikawa, O., R. B. Goodman, M. C. Johnson II, and T. R. Martin. 1996. Sensitive and specific immunoassays for rabbit IL-8 and MCP-1: two important cytokines that regulate leukocyte migration in the lungs. J. Immunol. Methods 197:19-29.
9. Johnson, M. C., H. O. Kajikawa, R. B. Goodman, V. A. Wong, S. M. Mongovin, and T. R. Martin. 1996. Molecular expression of the α-chemokine rabbit GRO in Escherichia coli and characterization of its production by lung cells in vitro and in vivo. J. Biol. Chem. 271:10853-10858.
10. Williamson, D. F., R. A. Parker, and J. Kendrick. 1989. The box plot: a simple visual method to interpret data. Ann. Intern. Med. 110:916-921.
11. Kleinbaum, D. G., L. L. Kupper, and K. E. Muller. 1988. Applied Regression Analysis and other Multivariable Methods. PWS-Kent Publishing Co., Boston, MA, p. 32.
12. Siegel, S., and N. J. Castellan. 1988. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, Inc., New York. 206-216.
13. Denis, M., L. Guojian, M. Widmer, and A. Cantin. 1994. A mouse model of lung injury induced by microbial products: implication of tumor necrosis factor. Am. J. Respir. Cell Mol. Biol. 10:658-664.
14. Li, X. Y., K. Donaldson, D. Brown, and W. MacNee. 1995. The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation. Am. J. Respir. Crit. Care Med. 13:185-195.
15. Martin, T. R., J. C. Mathison, P. S. Tobias, D. J. Leturcq, A. M. Moriarty, R. J. Maunder, and R. J. Ulevitch. 1992. Lipolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipolysaccharide. Implications for cytokine production in normal and injured lungs. J. Clin. Invest. 90:2209-2219.
16. Konig, B., and W. Konig. 1993. Induction and suppression of cytokine release (tumor necrosis factor-α, interleukin-6, interleukin-1β) by Escherichia coli: pathogenicity factors (adhesins, α-hemolysin). Imimmology 78:526-533.
17. Repine, J. E., and C. J. Beehler. 1991. Neutrophils and the adult respiratory distress syndrome: two interlocking perspectives. Am. Rev. Respir. Dis. 144:251-252.
18. Shasby, D. M., S. S. Shasby, and M. J. Peach. 1983. Granulocytes and phorbol myrislate acetate increase permeability to albumin of cultured endothelial monolayers and isolated perfused lungs. Am. Rev. Respir. Dis. 127:72-76.
19. Heflin, A. C. Jr., and K. L. Brigham. 1981. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68:1253-1260.
20. McKenna, P. J., D. L. Rosolia, Y. Ishihara, K. H. Albertine, N. C. Staub, and M. H. Gee. 1992. Downregulation of blood and bone marrow neutrophils decreases expression of acute lung injury in sheep. Am. J. Physiol. 263:H1492-1498.
21. Shasby, D. M., K. M. Vanbenthuysen, R. M. Tate, S. S. Shasby, I. McMurtry, and J. E. Repine. 1982. Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals. Am. Rev. Respir. Dis. 125:443-447.
22. 4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 84:1609-1619.
23. Wiener-Kronish, J. P., K. H. Albertine, and M. A. Matthay. 1991. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest. 88:864-875.
24. Kudoh, I., J. P. Wiener-Kronish, W. Hashimoto, J. F. Pittet, and D. Frank. 1994. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 267:L551-L556.
25. Jones, H. A., R. J. Clark, C. G. Rhodes, J. B. Schofield, T. Krausz, and C. Haslett. 1994. In vivo measurement of neutrophil activity in experimental lung inflammation. Am. J. Respir. Crit. Care Med. 149:1635-1639.
26. Standiford, T. J., S. L. Kunkel, and R. M. Strieter. 1993. Interleukin-8: a major mediator of acute pulmonary inflammation. Regional Immunol. 5:134-141.
27. Rodriguez, J. L., C. G. Miller, L. E. DeForge, L. Kelty, C. J. Shanley, R. H. Bartlett, and D. G. Remick. 1992. Local production of interleukin-8 is associated with nosocomial pneumonia. J. Trauma 33:74-81.
28. Miller E. J., S. Nagao, D. Griffith, R. J. Maunder, T. R. Martin, J. P. Wiener-Kronish, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-432.
29. Leonard E. J., T. Yoshimura, A. Rot, K. Noer, A. Walz, M. Baggliolini, and D. A. Walz. 1991. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor. J. Leukocyte Biol. 49:258-265.
30. Webb L. M., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. U.S.A. 90:7158-7162.
31. Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17-46.
32. Folkesson, H. G., M. A. Matthay, C. A. Hebert, and V. C. Broaddus. 1995. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J. Clin. Invest. 96:107-116.
33. Martin, T. R., B. P. Pistorese, L. D. Hudson, and R. J. Maunder. 1991. Function of lung and blood neutrophils in patients with the adult respiratory distress syndrome. Implications for the pathogenesis of lung infections. Am. Rev. Respir. Dis. 144:254-262.